These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23829794)

  • 1. Editorial for issue 2 of 2013, Journal of Evidence Based Medicine.
    Clarke M; Li Y
    J Evid Based Med; 2013 May; 6(2):65. PubMed ID: 23829794
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of recurrent hepatocellular carcinoma after liver transplantation.
    Davis E; Wiesner R; Valdecasas J; Kita Y; Rossi M; Schwartz M
    Liver Transpl; 2011 Oct; 17 Suppl 2():S162-6. PubMed ID: 21688382
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppression and hepatocellular carcinoma.
    Schlitt HJ; Mornex F; Shaked A; Trotter JF
    Liver Transpl; 2011 Oct; 17 Suppl 2():S159-61. PubMed ID: 21506251
    [No Abstract]   [Full Text] [Related]  

  • 4. Should the liver transplant criteria for hepatocellular carcinoma be different for deceased donation and living donation?
    Grant D; Fisher RA; Abecassis M; McCaughan G; Wright L; Fan ST
    Liver Transpl; 2011 Oct; 17 Suppl 2():S133-8. PubMed ID: 21634006
    [No Abstract]   [Full Text] [Related]  

  • 5. Improvement of survival by surgery in the treatment of hepatocellular carcinoma: evidence or non-evidenced-based?
    Adam R
    Ann Surg Oncol; 2004 May; 11(5):460-1. PubMed ID: 15078638
    [No Abstract]   [Full Text] [Related]  

  • 6. Liver transplantation for hepatocellular carcinoma: Foucault pendulum versus evidence-based decision.
    Bruix J; Fuster J; Llovet JM
    Liver Transpl; 2003 Jul; 9(7):700-2. PubMed ID: 12827556
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial for issue 1 of 2012, Journal of Evidence Based Medicine.
    Clarke M; Li Y
    J Evid Based Med; 2012 Feb; 5(1):1. PubMed ID: 23528113
    [No Abstract]   [Full Text] [Related]  

  • 8. Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantation.
    Kneteman N; Livraghi T; Madoff D; de Santibañez E; Kew M
    Liver Transpl; 2011 Oct; 17 Suppl 2():S117-27. PubMed ID: 21584926
    [No Abstract]   [Full Text] [Related]  

  • 9. Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma?
    Yao FY; Breitenstein S; Broelsch CE; Dufour JF; Sherman M
    Liver Transpl; 2011 Oct; 17 Suppl 2():S109-16. PubMed ID: 21584927
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial for issue 4 of 2011, Journal of Evidence Based Medicine.
    Clarke M; Li Y
    J Evid Based Med; 2011 Nov; 4(4):203. PubMed ID: 23672749
    [No Abstract]   [Full Text] [Related]  

  • 11. What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation?
    Olthoff KM; Forner A; Hübscher S; Fung J
    Liver Transpl; 2011 Oct; 17 Suppl 2():S26-33. PubMed ID: 21656653
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial for issue 1 of 2011, Journal of Evidence Based Medicine.
    Clarke M; Li Y
    J Evid Based Med; 2011 Feb; 4(1):1. PubMed ID: 21342477
    [No Abstract]   [Full Text] [Related]  

  • 13. Which matters most: number of tumors, size of the largest tumor, or total tumor volume?
    Germani G; Gurusamy K; Garcovich M; Toso C; Fede G; Hemming A; Suh KS; Weber A; Burroughs AK
    Liver Transpl; 2011 Oct; 17 Suppl 2():S58-66. PubMed ID: 21584928
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial for issue 3 of 2013, Journal of Evidence Based Medicine.
    Clarke M; Li Y
    J Evid Based Med; 2013 Aug; 6(3):125. PubMed ID: 24325367
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatocellular carcinoma: current management and perspectives for the future.
    Rahbari NN; Mehrabi A; Mollberg NM; Müller SA; Koch M; Büchler MW; Weitz J
    Ann Surg; 2011 Mar; 253(3):453-69. PubMed ID: 21263310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiofrequency ablation of malignant liver tumours].
    Drug VL; Bugioeanu C; Burcoveanu C; Balan G; Prelipcean CC; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(1):23-31. PubMed ID: 19292074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma: a pledge for evidence-based medicine.
    Braillon A; Nguyen-Khac E
    Am J Med; 2008 Oct; 121(10):e7; author reply e11-2. PubMed ID: 18823845
    [No Abstract]   [Full Text] [Related]  

  • 18. 2010 International Consensus Conference on Liver Transplantation for Hepatocellular Carcinoma: texts of experts.
    Lesurtel M; Clavien PA
    Liver Transpl; 2011 Oct; 17 Suppl 2():S1-5. PubMed ID: 21656651
    [No Abstract]   [Full Text] [Related]  

  • 19. Markers for microvascular invasion in hepatocellular carcinoma: where do we stand?
    Gouw AS; Balabaud C; Kusano H; Todo S; Ichida T; Kojiro M
    Liver Transpl; 2011 Oct; 17 Suppl 2():S72-80. PubMed ID: 21714066
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival and health-related quality of life in patients with spinal metastases originated from primary hepatocellular carcinoma.
    Zheng W; Wu J; Xiao JR; Guo Q
    J Evid Based Med; 2013 May; 6(2):81-9. PubMed ID: 23829800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.